Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time

Journal of Infectious Diseases

Volumn 207, Issue 8, 2013, Pages 1206-1215

  Bull, Marta E ^a,b,c   Heath, Laura M ^a   McKernan Mullin, Jennifer L ^c   Kraft, Kelli M ^b,c   Acevedo, Luis ^b,c   Hitti, Jane E ^a   Cohn, Susan E ^e,f   Tapia, Kenneth A ^a   Holte, Sarah E ^a,d   Dragavon, Joan A ^a   Coombs, Robert W ^a,b   Mullins, James I ^a,b   Frenkel, Lisa M ^a,c  

^a Department of Pediatrics ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

compartmentalization; female genital tract; genetic distances; HIV; monotypic HIV; phylogenetics; uterine cervix; viral lineages

Indexed keywords

ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL LINEAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; FEMALE GENITAL SYSTEM; GENE AMPLIFICATION; GENE SEQUENCE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LONGITUDINAL STUDY; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; VIRUS CONCENTRATION; VIRUS REPLICATION;

CROSS-SECTIONAL STUDIES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; GENES, VIRAL; GENITALIA, FEMALE; GENOTYPE; GLYCOSYLATION; HIV INFECTIONS; HIV-1; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; PHYLOGENY; REPRODUCTIVE TRACT INFECTIONS; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; SPECIES SPECIFICITY; TIME FACTORS; VIRUS REPLICATION;

EID: 84875602878     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit016     Document Type: Article

References (49)

1. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Nat Acad Sci U S A 2008; 105:7552-7.
2. Gottlieb GS, Heath L, Nickle DC, et al. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis 2008; 197:1011-5.
3. Salazar-Gonzalez JF, Salazar MG, Keele BF, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009; 206:1273-89.
4. Kearney M, Maldarelli F, Shao W, et al. Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol 2009; 83:2715-27.
5. Fischer W, Ganusov VV, Giorgi EE, et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One; 5:e12303.
6. Li H, Bar KJ, Wang S, et al. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog; 2010; 6:e1000890.
7. Hahn BH, Shaw GM, Taylor ME, et al. Genetic variation in HTLVIII/ LAV over time in patients with AIDS or at risk for AIDS. Science 1986; 232:1548-53.
8. Holmes EC, Zhang LQ, Simmonds P, Ludlam CA, Brown AJ. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Nat Acad Sci U S A 1992; 89:4835-9.
9. Korber BT, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68:7467-81.
10. Shankarappa R, Margolick JB, Gange SJ, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999; 73:10489-502.
11. Poss M, Rodrigo AG, Gosink JJ, et al. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol 1998; 72:8240-51.
12. Haaland RE, Sullivan ST, Evans-Strickfaden T, Lennox JL, Hart CE. Female genital tract shedding of CXCR4-tropic HIV type 1 is associated with a majority population of CXCR4-tropic HIV type 1 in blood and declining CD4(+) cell counts. AIDS Res Hum Retrov 2012; 11:1524-32.
13. Andreoletti L, Skrabal K, Perrin V, et al. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women. J Clin Microbiol 2007; 45:1838-42.
14. Kemal KS, Foley B, Burger H, et al. HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Nat Acad Sci U S A 2003; 100:12972-7.
15. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. J Infect Dis 1998; 177:1100-3.
16. Sullivan ST, Mandava U, Evans-Strickfaden T, Lennox JL, Ellerbrock TVHart CE. Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status. J Virol 2005; 79:9799-809.
17. Chomont N, Hocini H, Gresenguet G, et al. Early archives of genetically- restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1. AIDS (London) 2007; 21:153-62.
18. Philpott S, Burger H, Tsoukas C, et al. Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. J Virol 2005; 79:353-63.
19. Chaudhary S, Noel RJ, Rodriguez N, et al. Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females. Virology 2011; 417:320-6.
20. Si-Mohamed A, Kazatchkine MD, Heard I, et al. Selection of drugresistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis 2000; 182:112-22.
21. Min SS, Corbett AH, Rezk N, et al. Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women. J Acq Immun Def Synd (1999) 2004; 37:1577-80.
22. Lawn SD, Subbarao S, Wright TC Jr., et al. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis 2000; 181:1950-6.
23. Ellerbrock TV, Lennox JL, Clancy KA, et al. Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis 2001; 184:28-36.
24. Kovacs A, Wasserman SS, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358:1593-601.
25. Panther LA, Tucker L, Xu C, Tuomala RE, Mullins JI, Anderson DJ. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis 2000; 181:555-63.
26. Poss M, Martin HL, Kreiss JK, et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 1995; 69:8118-22.
27. Adal M, Ayele W, Wolday D, et al. Evidence of genetic variability of human immunodeficiency virus type 1 in plasma and cervicovaginal lavage in Ethiopian women seeking care for sexually transmitted infections. AIDS Res Hum Retrov 2005; 21:649-53.
28. Bull M, Learn G, Genowati I, et al. Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations. PLoS One 2009; 4:e7122.
29. Bull ME, Learn GH, McElhone S, et al. Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus. J Virol 2009; 83: 6020-8.
30. Tobin NH, Learn GH, Holte SE, et al. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol 2005; 79:9625-34.
31. Bailey JR, Sedaghat AR, Kieffer T, et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol 2006; 80:6441-57.
32. Brennan TP, Woods JO, Sedaghat AR, Siliciano JD, Siliciano RF, Wilke CO. Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol 2009; 83:8470-81.
33. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS (London) 2000; 14:2101-7.
34. Slatkin M, Maddison WP. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 1989; 123:603-13.
35. Critchlow DEL, Shuying L, Nourijelyani K, Pearl DK. Some statistical methods for phylogenetic trees with application to HIV fisease. Math Comp Model 2000; 32:69-81.
36. Hudson RR. A new statistic for detecting genetic differentiation. Genetics 2000; 155:2011-4.
37. Pond SL, Frost SD, Muse SV. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005; 21:676-9.
38. Mitchell CM, Balkus J, Agnew KJ, et al. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retrov 2008; 24:667-71.
39. Mitchell C, Paul K, Agnew K, Gaussman R, Coombs RW, Hitti J. Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J Clin Microbiol 2011; 49:735-6.
40. Zuckerman RA, Whittington WL, Celum CL, et al. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. J Infect Dis 2004; 190:156-61.
41. Guindon S, Lethiec F, Duroux P, Gascuel O. PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 2005; 33:W557-9.
42. Deng W, Maust BS, Nickle DC, et al. DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotechniques 2010; 48:405-8.
43. Holmes EC, Zhang LQ, Simmonds P, Ludlam CA, Leigh Brown AJ. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Nat Acad Sci U S A 1992; 89:4835-9.
44. Page RDM, Holmes EC. Molecular evolution: a phylogenetic approach. Oxford: Blackwell Science Ltd, 1998.
45. Zarate S, Pond SL, Shapshak P, Frost SD. Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. J Virol 2007; 81:6643-51.
46. Mitchell C, Hitti J, Paul K, et al. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retrov 2011; 27:35-9.
47. Delwart EL, Mullins JI, Gupta P, et al. Human immunodeficiency virus type 1 populations in blood and semen. J Virol 1998; 72: 617-23.
48. Martin HL Jr, Nyange PM, Richardson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-9.
49. Rodrigo AG, Goracke PC, Rowhanian K, Mullins JI. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS AIDS Res Hum Retrov 1997; 13:737-42.